Literature DB >> 3141683

Clinical consequences of hyperlipidaemia.

G R Thompson1.   

Abstract

Hyperlipidaemia is a common and important clinical entity which frequently has a genetic basis. The chief features of severe hypertriglyceridaemia are eruptive xanthomata and acute pancreatitis, whereas most forms of hypercholesterolaemia are associated with premature coronary heart disease. This applies especially to familial hypercholesterolaemia, which is also characterized by tendon xanthomata. Better recognition of hyperlipidaemia allied to recent improvements in treatment should help reduce the frequency of its disabling and sometimes fatal consequences.

Entities:  

Mesh:

Year:  1988        PMID: 3141683     DOI: 10.1007/bf01800567

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  27 in total

1.  Plasma high-density lipoproteins and ischemic heart disease: studies in a large kindred with familial hypercholesterolemia.

Authors:  D Streja; G Steiner; P O Kwiterovich
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

2.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

Review 3.  Classification of hyperlipidaemias and hyperlipoproteinaemias.

Authors:  J L Beaumont; L A Carlson; G R Cooper; Z Fejfar; D S Fredrickson; T Strasser
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

Review 4.  Fat transport in lipoproteins--an integrated approach to mechanisms and disorders.

Authors:  D S Fredrickson; R I Levy; R S Lees
Journal:  N Engl J Med       Date:  1967-01-19       Impact factor: 91.245

Review 5.  Receptor-mediated endocytosis: concepts emerging from the LDL receptor system.

Authors:  J L Goldstein; M S Brown; R G Anderson; D W Russell; W J Schneider
Journal:  Annu Rev Cell Biol       Date:  1985

6.  Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

Authors:  M J Martin; S B Hulley; W S Browner; L H Kuller; D Wentworth
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

7.  The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia.

Authors:  D L Sprecher; J M Hoeg; E J Schaefer; L A Zech; R E Gregg; E Lakatos; H B Brewer
Journal:  Metabolism       Date:  1985-03       Impact factor: 8.694

8.  A host of hypercholesterolaemic homozygotes in South Africa.

Authors:  H C Seftel; S G Baker; M P Sandler; M B Forman; B I Joffe; D Mendelsohn; T Jenkins; C J Mieny
Journal:  Br Med J       Date:  1980-09-06

9.  Plasma exchange in the management of homozygous familial hypercholesterolaemia.

Authors:  G R Thompson; R Lowenthal; N B Myant
Journal:  Lancet       Date:  1975-05-31       Impact factor: 79.321

10.  Hypertriglyceridemia associated with deficiency of apolipoprotein C-II.

Authors:  W C Breckenridge; J A Little; G Steiner; A Chow; M Poapst
Journal:  N Engl J Med       Date:  1978-06-08       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.